Immunotech Biopharm Balance Sheet Health

Financial Health criteria checks 4/6

Immunotech Biopharm has a total shareholder equity of CN¥387.8M and total debt of CN¥321.2M, which brings its debt-to-equity ratio to 82.8%. Its total assets and total liabilities are CN¥1.0B and CN¥650.0M respectively.

Key information

82.8%

Debt to equity ratio

CN¥321.22m

Debt

Interest coverage ration/a
CashCN¥266.88m
EquityCN¥387.77m
Total liabilitiesCN¥650.02m
Total assetsCN¥1.04b

Recent financial health updates

Recent updates

Will Immunotech Biopharm (HKG:6978) Spend Its Cash Wisely?

Dec 30
Will Immunotech Biopharm (HKG:6978) Spend Its Cash Wisely?

We're Hopeful That Immunotech Biopharm (HKG:6978) Will Use Its Cash Wisely

Apr 29
We're Hopeful That Immunotech Biopharm (HKG:6978) Will Use Its Cash Wisely

Financial Position Analysis

Short Term Liabilities: 6978's short term assets (CN¥316.2M) exceed its short term liabilities (CN¥174.5M).

Long Term Liabilities: 6978's short term assets (CN¥316.2M) do not cover its long term liabilities (CN¥475.5M).


Debt to Equity History and Analysis

Debt Level: 6978's net debt to equity ratio (14%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 6978's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 6978 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 6978 has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 11.3% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.